Literature DB >> 8366861

Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals.

J M Requena1, M Soto, F Guzman, A Maekelt, O Noya, M E Patarroyo, C Alonso.   

Abstract

In the present paper we describe the analysis of the immunological recognition by sera of healthy individuals and chagasic patients of the Trypanosoma cruzi heat shock 70 kDa protein. By a Falcon Assay Screening Test, using as antigen an ATP-agarose purified T. cruzi hsp70, it has been found that the sera of infected patients as well as of that of healthy individuals show reactivity against the hsp70 protein but that the reactivity of the sera of patients is in general significantly higher than that of healthy individuals. The analysis of the reactivity of the chagasic sera against a collection of peptides covering 92% of the protein has shown that more than 50% of the peptides gave a positive response but only against a few peptides did we observe high reactivity in a wide spectrum of sera. Only four peptides (numbers 9, 12, 14 and 47) were recognized by all sera tested with high reactivity values. The sera of healthy individuals also showed reactivity against a large percentage of peptides but with lower values. It was observed that particular peptides showing high reactivity against the sera of healthy donors also show high reactivity against patients' sera. However, the general pattern of reactivity against the peptides is different in chagasic and healthy sera. The immunodominant peptides map in the highly conserved as well as in the less conserved part of the hsp70 molecule. The 1/3 C-terminal, being the least conserved part of the molecule, seems to be the least immunogenic. Mapping of the epitopes led to the identification of particular immunogenic motifs within individual peptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8366861     DOI: 10.1016/0161-5890(93)90158-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.

Authors:  Ana Fernández-Villegas; Elena Pérez-Antón; Inmaculada Gómez; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Ángel Del Pozo; Maialen Ceballos; Eduardo Andrés-León; Miguel Ángel López-Ruz; Eusebio Gainza; Enrique Oquiñena; Manuel Segovia; Manuel Carlos López
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

2.  Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu/nu BALB/c mice.

Authors:  A I Rico; G Del Real; M Soto; L Quijada; C Martinez-A; C Alonso; J M Requena
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

3.  During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins.

Authors:  M Soto; J M Requena; L Quijada; S O Angel; L C Gomez; F Guzman; M E Patarroyo; C Alonso
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

4.  Short-term follow-up of chagasic patients after benzonidazole treatment using multiple serological markers.

Authors:  Ana Fernández-Villegas; María Jesús Pinazo; Concepción Marañón; M Carmen Thomas; Elizabeth Posada; Bartolomé Carrilero; Manuel Segovia; Joaquim Gascon; Manuel C López
Journal:  BMC Infect Dis       Date:  2011-07-31       Impact factor: 3.090

5.  Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.

Authors:  Ivonne D Flechas; Adriana Cuellar; Zulma M Cucunubá; Fernando Rosas; Víctor Velasco; Mario Steindel; María del Carmen Thomas; Manuel Carlos López; John Mario González; Concepción Judith Puerta
Journal:  BMC Infect Dis       Date:  2009-11-25       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.